Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition.IngredientsBPC 157 (L-Valine L-Glutamine L-Glycine L-Proline L-Lysine L-Alanine L-Arginine L-Histidine L-Leucine L-Tyrosine L-Serine L-Threonine L-Isoleucine L-Trypophan L-Methionine)BPC-159 (L-Valine L-Glutamine L-Glycine L-Proline L-Lysine L-Alanine L-Arginine L-Histidine L-Leucine L-Tyrosine L-Serine L-Threonine L-Isoleucine L-Tryptophan L-Methionine) Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition
These effects are often dose-dependent and more prominent during initial administration
What makes the evidence compelling for legal purposes is the consistency across multiple independent studies, the dose-response relationship (higher risk with longer use), and the fact that non-diabetic users taking the drugs solely for fat loss show the highest risk increase
Glucagon-receptor agonism raises energy expenditure and mobilizes fat, which could in theory favor fat loss over muscle loss
Decide now what circumstances will trigger medication resumption